Search Results

There are 21184 results for: content related to: The genetics of antiplatelet drug resistance

  1. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  2. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  3. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  4. Antiplatelet Agents

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Samuel Chackalamannil

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc175

  5. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  6. You have free access to this content
    Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

    Journal of Bone and Mineral Research

    Volume 27, Issue 11, November 2012, Pages: 2373–2386, Susanne Syberg, Andrea Brandao-Burch, Jessal J Patel, Mark Hajjawi, Timothy R Arnett, Peter Schwarz, Niklas R Jorgensen and Isabel R Orriss

    Version of Record online : 16 OCT 2012, DOI: 10.1002/jbmr.1690

  7. You have free access to this content
    Clopidogrel Resistance: Identifying and Overcoming a Barrier to Effective Antiplatelet Treatment

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: e100–e111, Shinichiro Uchiyama

    Version of Record online : 31 JUL 2011, DOI: 10.1111/j.1755-5922.2010.00202.x

  8. You have free access to this content
    Oral presentations

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 1–316,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_1.x

    Corrected by:

    Corrigendum

    Vol. 7, Issue 8, 1436, Version of Record online: 23 JUL 2009

  9. You have full text access to this OnlineOpen article
    Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

    Cardiovascular Therapeutics

    Volume 27, Issue 4, Winter 2009, Pages: 259–274, Steen Husted and J.J.J. Van Giezen

    Version of Record online : 10 JUL 2009, DOI: 10.1111/j.1755-5922.2009.00096.x

  10. You have free access to this content
    Clinical implications of drug–drug interactions with P2Y12 receptor inhibitors

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 1, January 2014, Pages: 2–13, J. M. Siller-Matula, D. Trenk, S. Krähenbühl, A. D. Michelson and G. Delle-Karth

    Version of Record online : 9 JAN 2014, DOI: 10.1111/jth.12445

  11. Personalizing Antiplatelet Therapy With Clopidogrel

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 476–485, D Trenk, O Zolk, M F Fromm, F-J Neumann and W Hochholzer

    Version of Record online : 5 SEP 2012, DOI: 10.1038/clpt.2012.133

  12. You have free access to this content
    Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 8, August 2010, Pages: 1820–1827, H. M. JUDGE, S. B. PATIL, R. J. BUCKLAND, J. A. JAKUBOWSKI and R. F. STOREY

    Version of Record online : 21 MAY 2010, DOI: 10.1111/j.1538-7836.2010.03925.x

  13. Clopidogrel Resistance: Pharmacokinetic or Pharmacogenetic?

    The Journal of Clinical Pharmacology

    Volume 49, Issue 5, May 2009, Pages: 506–512, Neville F. Ford

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009332433

  14. You have free access to this content
    Clopidogrel “Resistance”: Where are We Now?

    Cardiovascular Therapeutics

    Volume 31, Issue 1, February 2013, Pages: 3–11, Zeshan Qureshi and Alex R. Hobson

    Version of Record online : 3 AUG 2011, DOI: 10.1111/j.1755-5922.2011.00296.x

  15. Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans

    The Journal of Clinical Pharmacology

    Volume 50, Issue 2, February 2010, Pages: 126–142, Dr Nagy A. Farid, Dr Atsushi Kurihara and Dr Steven A. Wrighton

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009343005

  16. You have free access to this content
    A case–control study on platelet reactivity in patients with coronary stent thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 5, May 2011, Pages: 909–916, H. J. BOUMAN, J. W. VAN WERKUM, N. J. BREET, H. TEN CATE, C. M. HACKENG and J. M. TEN BERG

    Version of Record online : 6 MAY 2011, DOI: 10.1111/j.1538-7836.2011.04255.x

  17. Genetic Causes of Clopidogrel Nonresponsiveness: Which Ones Really Count?

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 3, March 2010, Pages: 265–274, Dr. Kathryn M. Momary, Dr. Michael P. Dorsch and Dr. Eric R. Bates

    Version of Record online : 5 APR 2012, DOI: 10.1592/phco.30.3.265

  18. Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 9, September 2009, Pages: 1089–1102, Dr. Paul P. Dobesh

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.9.1089

  19. You have free access to this content
    Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 12, December 2007, Pages: 2429–2436, J. T. BRANDT, S. L. CLOSE, S. J. ITURRIA, C. D. PAYNE, N. A. FARID, C. S. ERNEST II, D. R. LACHNO, D. SALAZAR and K. J. WINTERS

    Version of Record online : 27 SEP 2007, DOI: 10.1111/j.1538-7836.2007.02775.x

  20. Clopidogrel Use in End-Stage Kidney Disease

    Seminars in Dialysis

    Volume 28, Issue 3, May–June 2015, Pages: 276–281, Bassem Y. Tanios, Houssam S. Itani and Deborah L. Zimmerman

    Version of Record online : 5 DEC 2014, DOI: 10.1111/sdi.12338